Menu

Myrbetriq is a prescription medicine for adults used to treat
overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Savings & Support

In this section, you'll learn about:

  • Enrolling for savings offers through
  • Email or Text*
  • Assistance for those who can't
    afford to pay for Myrbetriq*

*Subject to eligibility.
Restrictions may apply.

Momentum Program

A program designed to help you start strong and stay on track

The Momentum Program was designed to support and encourage those taking Myrbetriq with tips, tools and savings to help you on your treatment journey. Helpful support resources are delivered right to your inbox or mailbox.

momentum program, oab support

Thank you for registering

Thank you for registering to receive emails from the Momentum Program. You can look forward to information, recipes, exercises, and tools to help you manage your OAB symptoms.

Savings

savings on myrbetriq price savings on myrbetriq price

If you're eligible, you can get your first prescription for $0† and save up to $70 every month for a full year!‡

The Momentum Program offers savings for eligible patients being treated with Myrbetriq for their OAB symptoms. With the Momentum Savings Card, you may be eligible for the following:

  • Get your first month's prescription at no cost†
  • Save a maximum total of $840 for 12 uses of your Myrbetriq prescription‡

You are still responsible for the first $20, plus any amount over $90 for each prescription. Find out today if you are eligible. Please read the eligibility restrictions below.

Enroll Online

Enroll Online

  • You will receive your savings and support via email or mail.
  • Refill reminders will be sent via email.
  • You can download your savings card to your mobile wallet after enrollment.
Enroll Now

Please read the eligibility restrictions below.

Enroll by Text

Enroll by Text

  • You will receive your savings and support via SMS (text messages).
  • Refill reminders will be sent via text.
  • You can download your savings card to your mobile wallet after enrollment.
Text MSAVE to 26789§
Text MSAVE to 26789§

§Subject to eligibility. Restrictions may apply. No-cost offer applies to one-month prescriptions only. Not available to patients paying cash. Msg & data rates may apply. Msg frequency varies. Text HELP for info, STOP to end. For the Momentum Program, clicktap here for applicable Terms and Conditions. View Privacy Policy. For Text to Save, clicktap here to view Eligibility and Terms and Conditions.

Eligibility Restrictions

TO THE PATIENT: Patients paying cash are not eligible to receive the first prescription at no cost. This offer is not valid for patients whose prescription claims are reimbursed, in whole or in part, by any state or federal government program, including, but not limited to, Medicaid, Medicare, Medigap, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, CHAMPUS, Puerto Rico Government Health Insurance, or any State Patient or
Pharmaceutical Assistance Program. This offer is void where prohibited by law. Certain rules and restrictions apply. This program is not insurance.

†Subject to eligibility. Restrictions may apply. No-cost offer applies to one-month prescriptions only. Not available to patients paying cash.
‡Patient is responsible for the first $20 plus any differential over $90 on each prescription.

Help Paying for Myrbetriq

If you're concerned about paying for Myrbetriq, we're here to help

You may be eligible to receive Myrbetriq at no cost. The Astellas Patient Assistance Program can determine if you are eligible for enrollment based on your insurance status and other criteria. To learn more, visit www.astellaspharmasupportsolutions.com.

Astellas Pharma Support Solutions seeks to
help patients through the Astellas Patient Assistance Program, benefit verification, and the prior authorization process.

Next Section
Patient Resources
Prev Section
Getting Started
Previous:
Getting Started
Next:
Patient Resources

Use of Myrbetriq

MYRBETRIQ® (mirabegron extended-release tablets) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Important Safety Information

Do not take MYRBETRIQ if you are allergic to mirabegron or any ingredients in MYRBETRIQ.

MYRBETRIQ may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. You and your doctor should check your blood pressure while you are taking MYRBETRIQ. Call your doctor if you have increased blood pressure.

MYRBETRIQ may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream.

MYRBETRIQ may cause an allergic reaction with swelling of the face, lips, throat or tongue with or without difficulty breathing. Stop using MYRBETRIQ and go to the nearest hospital emergency room right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines especially thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®) or solifenacin succinate (VESIcare®). MYRBETRIQ may affect the way other medicines work, and other medicines may affect how MYRBETRIQ works.

Before taking MYRBETRIQ, tell your doctor about all of your medical conditions, including if you have liver or kidney problems.

The most common side effects of MYRBETRIQ include high blood pressure, pain or swelling of the
nose or throat (nasopharyngitis), urinary tract infection, and headache.

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for MYRBETRIQ® (mirabegron extended‑release tablets).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

You are now leaving myrbetriq.com

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to Twitter.

You are now leaving myrbetriq.com. The website you are linking to is not owned by Astellas. Astellas is not responsible for the services on this site.
Continue to Twitter.

You are now leaving myrbetriq.com. The website you are linking to is not owned by Astellas. Astellas is not responsible for the services on this site.
Continue to Facebook.

You are now leaving myrbetriq.com. The third-party website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site. The third-party website is subject to its own Terms of Use and Privacy Policy. Astellas makes no representations as to the accuracy of the information contained on third-party websites. By clicking CONTINUE, you acknowledge that Astellas does not endorse or recommend any HCP associated with the third-party website, nor do we make any representations about the quality of medical care those professionals can provide. Astellas makes no guarantee that using the third-party website will result in the outcome you desire. The physician has no obligation to prescribe Myrbetriq and may instead prescribe another medication or no medication. It is wholly and solely your responsibility to assess the qualifications of a potential healthcare professional, and to discuss with them your symptoms as well as the risks and benefits of any potential treatment. You are responsible for any charges associated with services offered by the third-party website and should be aware that the third party may not accept medical insurance. ASTELLAS AND ITS AFFILIATES DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON INFORMATION PROVIDED TO YOU BY ANY HEALTHCARE PROFESSIONAL OR THE
THIRD-PARTY WEBSITE.

Note: The cost of a telehealth consultation is determined by and paid directly to the third-party telehealth company.

If you do not wish to leave Myrbetriq.com, click CANCEL, or click CONTINUE to go to the third-party website.

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to FDA Medwatch.

The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site. Astellas makes no representation as to the accuracy of the information contained on third-party websites. By entering your postal code and clicking continue, you acknowledge that Astellas does not endorse or recommend any healthcare professional associated with the third-party website, nor does Astellas make any representations about the quality of medical care those healthcare professionals can provide.
Continue to WebMD.

Continue Cancel

Our Doctor Conversation Guide can help you start the overactive bladder conversation.

Show it to your doctor at your appointment!

Get your Doctor Conversation Guide